| Date |
Announcements
|
Attachment |
| Dec 20, 2011 |
Appendix 3B - Issue of Options to Directors.pdf |
 PDF file - 350.73 KB
|
| Dec 8, 2011 |
Change in substantial holding for Avexa |
PDF file - 223.04 KB
|
| Nov 24, 2011 |
Result of Annual General Meeting |
PDF file - 94.39 KB
|
| Nov 23, 2011 |
Avexa files to extend ATC patent life |
PDF file - 375.7 KB
|
| Oct 31, 2011 |
Appendix 4C - Quarterly Cash Flow Report - September 2011 |
PDF file - 365.63 KB
|
| Oct 31, 2011 |
Notice of Annual General Meeting 2011 |
PDF file - 1.35 MB
|
| Oct 31, 2011 |
Proxy form AGM 2011 |
PDF file - 374.55 KB
|
| Aug 31, 2011 |
Directors Report |
PDF file - 321.15 KB
|
| Aug 31, 2011 |
Appendix 4E |
PDF file - 159.75 KB
|
| Jul 28, 2011 |
Appendix 4C - Quarterly Cash Flow Report - June 2011 |
PDF file - 368.37 KB
|
| Jul 6, 2011 |
Pharma Ventures Engagement |
PDF file - 199.27 KB
|
| Apr 27, 2011 |
Appendix 4C - quarterly |
PDF file - 315.4 KB
|
| Apr 1, 2011 |
Avexa to appoint new Chairman |
PDF file - 50.96 KB
|
| Mar 28, 2011 |
Avexa and FDA agree path forward for ATC |
PDF file - 55.56 KB
|
| Feb 28, 2011 |
Half Yearly Report and Account |
PDF file - 290.59 KB
|
Our attachments use Adobe PDF which means you may have to use an Acrobat Reader. You can
